Bioengineering Nanotechnology Initiative (STTR [R41/R42])
The summary for the Bioengineering Nanotechnology Initiative (STTR [R41/R42]) grant is detailed below.
This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants.
Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact.
If any section is incomplete, please visit the website for the National Institutes of Health, which is the U.S. government agency offering this grant.
Bioengineering Nanotechnology Initiative (STTR [R41/R42]): Purpose. Nanotechnology is the understanding and control of matter at dimensions between approximately 1 and 100 nanometers, where unique phenomena enable novel applications. Encompassing nanoscale science, engineering, and technology, nanotechnology involves imaging, measuring, modeling, and manipulating matter at this length scale. The purpose of this trans-NIH Funding Opportunity Announcement (FOA) is to stimulate Small Business Technology Transfer (STTR) grant applications that employ nanotechnology to enable the development of diagnostics and interventions for treating diseases. Mechanism of Support. This FOA will utilize the STTR (R41/R42) grant mechanisms for Phase I, Phase II, and Fast-Track applications and runs in parallel with a FOA of identical scientific scope, PA-10-150, that encourages applications under the Small Business Innovation Research (SBIR) (R43/R44) grant mechanisms. Funds Available and Anticipated Number of Awards. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. The total amount awarded and the number of awards will depend upon the quality, duration, and costs of the applications received. Future year amounts will depend on annual appropriations.
Federal Grant Title: | Bioengineering Nanotechnology Initiative (STTR [R41/R42]) |
Federal Agency Name: | National Institutes of Health |
Grant Categories: | Education Health Income Security and Social Services |
Type of Opportunity: | Discretionary |
Funding Opportunity Number: | PA-10-149 |
Type of Funding: | Grant |
CFDA Numbers: | 93.121 |
CFDA Descriptions: | Oral Diseases and Disorders Research |
Current Application Deadline: | May 07, 2013 |
Original Application Deadline: | May 07, 2013 |
Posted Date: | Apr 06, 2010 |
Creation Date: | Apr 06, 2010 |
Archive Date: | Jun 07, 2013 |
Total Program Funding: | |
Maximum Federal Grant Award: | |
Minimum Federal Grant Award: | |
Expected Number of Awards: | |
Cost Sharing or Matching: | No |
- Applicants Eligible for this Grant
- Small businesses
- Link to Full Grant Announcement
- Information not provided
- Grant Announcement Contact
- NIH OER [email protected]
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster [[email protected]] - Similar Government Grants
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • NIDCR Mentoring Network to Promote a Diverse Dental, Oral and Craniofacial Research Workfo...
- • Innovations for Healthy Living - Improving Minority Health and Eliminating Health Disparit...
- • Technologies for Improving Minority Health and Eliminating Health Disparities (R41/R42- Cl...
- • Building Interdisciplinary Research Careers in Women's Health (BIRCWH) (K12 Clinical Trial...
- • Epidemiological and Behavioral Research in Oral Health
- • Metagenomic Analyses of the Oral Microbiome
- • Phase Iii Clinical Trials in Oral Infectious Diseases
- More Grants from the National Institutes of Health
- • HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allow...
- • Technologies and Assays for Therapeutic Genome Editing INDs (U01, Clinical Trial Not Allow...
- • Developmental AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optio...
- • AIDS Research Center on Mental Health and HIV/AIDS (P30 Clinical Trial Optional)
- • NIH Directors Pioneer Award Program (DP1 Clinical Trial Optional)